Despite decades of research, virus infection remains a serious worldwide health threat. Clearly, new ideas and out-of-the-box approaches must be pursued. Many pathogenic viruses, such as influenza, human immunodeficiency, West Nile, and herpes virus, have surface envelopes loaded with carbohydrate-modified proteins encoded by the viral genome. Importantly, these surface "glycoproteins" are essential for viral infection, so preventing their assembly represents a very promising anti-viral target. The glycoproteins are generally of the N-linked class, which have glycans attached to asparagine residues. Mammalian host cells also synthesize their own N-linked glycoproteins. Thus, to produce their envelope proteins and attach the N-linked glycans, viruses must hijack the host's N-linked glycosylation pathway. This proposal will elucidate a novel anti-viral defense mechanism that prevents this hijacking, and which we hypothesize hinders infection. The antiviral mechanism uses a new signaling pathway elucidated by the P.I. specifically;the P.I. discovered that the common metabolite mannose-6-phosphate (M6P) is generated by glycogen breakdown for double-duty as a 2nd-messenger signaling molecule activated by viral infection. M6P signaling triggers a specific process for destruction of lipid-linked oligosaccharides (LLOs), which in mammals are conjugates of a 14-sugar oligosaccharide (Glc3Man9GlcNAc2) and the carrier lipid dolichol, connected by a pyrophosphate bond. Free Glc3Man9GlcNAc2 and dolichol phosphate result from LLO destruction by M6P signaling. A key point is that since LLOs are the glycan donors for N-linked glycosylation, LLO destruction by M6P signaling is predicted to impair viral N-glycosylation and infectivity. To elucidate this process, four Specific Aims are proposed for years 25-29 of this grant. The experiments will make extensive use of "Fluorophore-Assisted Carbohydrate Electrophoresis" (FACE), which we adapted for a comprehensive "one-stop shopping" view of the LLO pool, its substrates, and both its N-glycoprotein and degradation products.
Aim I will identify the sensor and effector of M6P, i.e. the proteins that receive M6P's signal, and that carry out M6P's specific instructions for LLO destruction.
Aim II will elucidate an unprecedented biosynthetic pathway for M6P 2nd messengers. This pathway is activated by the stress of viral infection, and is distinct from conventional pathways involved in synthesis of M6P as a metabolic precursor.
Aim III will identify ER stress-activated components of the pathway.
Aim I V will test the effect of M6P signaling on viral infectivity using herpes simplex virus-1 (HSV1). A critical prediction of Aim IV is that M6P signaling will inhibit HSV1 replication. The work will illustrate novel evolutionary aspects of anti-viral defense, and reformat long-standing dogma involving glycogen metabolism. A path for future experiments on the role of M6P signaling in viral pathogenesis and disease will be paved, leading to new anti-viral drugs and treatments.

Public Health Relevance

Infections by pathogenic viruses such as HIV, flu, herpes, and West Nile virus are major health problems in the USA. Treatment of such infections in the clinic is often difficult, with unacceptable frequencies of illness and death. This project will exploit a novel Achilles Heel of such viruses, based upon their requirement for carbohydrate, leading to future development of new anti-viral medicines and treatments.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Research Project (R01)
Project #
Application #
Study Section
Intercellular Interactions (ICI)
Program Officer
Marino, Pamela
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Texas Sw Medical Center Dallas
Schools of Medicine
United States
Zip Code
Philips, Katherine B; Kurtoglu, Metin; Leung, Howard J et al. (2014) Increased sensitivity to glucose starvation correlates with downregulation of glycogen phosphorylase isoform PYGB in tumor cell lines resistant to 2-deoxy-D-glucose. Cancer Chemother Pharmacol 73:349-61
Wang, Zhao V; Deng, Yingfeng; Gao, Ningguo et al. (2014) Spliced X-box binding protein 1 couples the unfolded protein response to hexosamine biosynthetic pathway. Cell 156:1179-92
Deng, Yingfeng; Wang, Zhao V; Tao, Caroline et al. (2013) The Xbp1s/GalE axis links ER stress to postprandial hepatic metabolism. J Clin Invest 123:455-68
Jelk, Jennifer; Gao, Ningguo; Serricchio, Mauro et al. (2013) Glycoprotein biosynthesis in a eukaryote lacking the membrane protein Rft1. J Biol Chem 288:20616-23
Zandberg, Wesley F; Gao, Ningguo; Kumarasamy, Jayakanthan et al. (2012) 5-thiomannosides block the biosynthesis of dolichol-linked oligosaccharides and mimic class I congenital disorders of glycosylation. Chembiochem 13:392-401
Gao, Ningguo; Shang, Jie; Huynh, Dang et al. (2011) Mannose-6-phosphate regulates destruction of lipid-linked oligosaccharides. Mol Biol Cell 22:2994-3009
Harrison, Kenneth D; Park, Eon Joo; Gao, Ningguo et al. (2011) Nogo-B receptor is necessary for cellular dolichol biosynthesis and protein N-glycosylation. EMBO J 30:2490-500
Rush, Jeffrey S; Gao, Ningguo; Lehrman, Mark A et al. (2009) Suppression of Rft1 expression does not impair the transbilayer movement of Man5GlcNAc2-P-P-dolichol in sealed microsomes from yeast. J Biol Chem 284:19835-42
Gao, Ningguo; Shang, Jie; Lehrman, Mark A (2008) Unexpected basis for impaired Glc3Man9GlcNAc2-P-P-dolichol biosynthesis by elevated expression of GlcNAc-1-P transferase. Glycobiology 18:125-34
Rush, Jeffrey S; Gao, Ningguo; Lehrman, Mark A et al. (2008) Recycling of dolichyl monophosphate to the cytoplasmic leaflet of the endoplasmic reticulum after the cleavage of dolichyl pyrophosphate on the lumenal monolayer. J Biol Chem 283:4087-93

Showing the most recent 10 out of 54 publications